Name: CYTOF Expected Dividend As Percentage Share Options Granted 2022-2022
Creator: U.S. Securities and Exchange Commission
License: https://www.sec.gov/privacy#dissemination

Altamira Therapeutics Ltd. Expected Dividend As Percentage Share Options Granted

Altamira Therapeutics Ltd. (CYTOF) reported Expected Dividend As Percentage Share Options Granted of 90.00% for the 0-month period ending 2022-10-21, per its 6-K/A filed 2023-08-21.

Discontinued › Notes

ifrs-full:ExpectedDividendAsPercentageShareOptionsGranted · last filed 2023-08-21

2022-10-21: Expected Dividend As Percentage Share Options Granted 0 month 90.00%.

Period end	Expected Dividend As Percentage Share Options Granted 0 month
2022-10-21	90.00% 6-K/A · filed 2023-08-21